Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.051 SEK | +40.11% | +64.52% | -46.32% |
Business Summary
Number of employees: 5
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Prognostic Gene Test
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | +98.59% |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Sweden
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | +98.59% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Fredrik Persson
CEO | Chief Executive Officer | - | 31/12/16 |
Lars Anders Koch
DFI | Director of Finance/CFO | - | 30/10/23 |
Emelie Berglund
CTO | Chief Tech/Sci/R&D Officer | - | - |
Gerald Andriole
CTO | Chief Tech/Sci/R&D Officer | - | 04/05/23 |
Chief Operating Officer | 52 | 31/12/19 | |
Katarina Sjoberg
LAW | General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | 31/12/12 | |
Director/Board Member | 72 | 31/12/18 | |
Michael Häggman
BRD | Director/Board Member | - | 31/12/17 |
Anders Lundberg
CHM | Chairman | - | 31/12/16 |
Mattias Prage
BRD | Director/Board Member | - | 31/12/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 119,460,007 | 14,952,566 ( 12.52 %) | 0 | 12.52 % |
Company contact information
Sector
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-46.32% | 3.33M | |
-15.77% | 8.49B | |
+60.25% | 4.08B | |
-43.01% | 2.42B | |
-9.98% | 2.42B | |
-3.24% | 2.33B | |
-3.40% | 2.01B | |
-19.79% | 1.53B | |
-40.57% | 1.26B | |
+9.11% | 1.07B |
- Stock Market
- Equities
- PROGEN Stock
- Company Prostatype Genomics AB